04. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Meningococcal Vaccine-Naive Participants Across a Broad Age Range (2-55 Years) in Japan

BACKGROUND: MenACYW-TT [MenQuadfi(®)] is a quadrivalent meningococcal conjugate vaccine, licensed for use in ages 2 years and older in USA. The vaccine is also licensed in ages 12 months and older in EU and certain other countries. We evaluated the safety and immunogenicity of MenACYW-TT compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Osamu, Ujiie, Mugen, Kikuchi, Hitoshi, Chansinghakul, Danaya, Inoue, Takahiro, Varghese, Kucku, Sirisuphmitr, Nuchra, Hashiguchi, Tomoyuki, Zambrano, Betzana, Nakama, Takahiro, Frago, Carina, Jordanov, Emilia, Dhingra, Mandeep S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644785/
http://dx.doi.org/10.1093/ofid/ofab466.207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644785/
http://dx.doi.org/10.1093/ofid/ofab466.207

Ejemplares similares